-
Godzilla Minus Zero Review: Takashi Yamazaki’s Anti-Nuclear Allegory
-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
DA Demands No-Work-No-Pay for Striking Municipal Workers in Coalition Talks
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
-
India's Retail Inflation Reaches 6.09% as Food Prices Accelerate
-
India's Wholesale Inflation Jumps to 12.29% as Fuel Costs Surge
-
Malta Emerges as Premier Low-Season Destination for UK Travelers
-
China's October Activity Data Reveal a Weak Start to the Fourth Quarter
-
Japan's Economy Edges Into Contraction as Costly Oil Weighs on Demand
-
Philippines Urges ASEAN and China to Accelerate South China Sea Code of Conduct
-
UK Home Asking Prices Drop £6,745 in November Amid High Mortgage Rates
-
Mbeki Claims No Progress Since 2018; Author Cites Infrastructure and Economic Gains
-
Alex Georgiev Sets Personal Record to Win NCAA Pole Vault at Penn Relays
-
Qatar's Amir and Venezuelan Acting President Discuss Energy Cooperation
-
SMX Brings a New Level of Transparency to Gold Trading Through trueGold Technology
-
GameSquare Holdings Reports 2026 Third Quarter Results with Revenue up 77% YoY and Net Income Reaches $10.1 Million
-
ValorPay UAB Goes Live on T2, the Eurosystem's Real-Time Settlement System
-
CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline
-
XCF Global Reports Third Quarter 2026 Financial Results & Affirms 2027 Outlook
-
NuRAN Wireless Eliminates Floating-Price Preferred Overhang and Locks In a Fixed C$1.20 Conversion Price
-
NextSource Materials Appoints Eugene Lee as Chief Financial Officer
-
International Battery Metals Ltd. Reports Second Quarter of Fiscal Year 2027 Financial Results
-
Abasca Resources Engages Northern Arc Public Affairs to Advance Federal Engagement on the Loki Flake Graphite Project
-
AsiaFIN Holdings Corp. Announces Third Quarter 2026 Results, Reporting Strong Nine-Month Financial Performance with Improved Margins
-
Thalia Therapeutics PLC Announces Promising Interim Phase I Data for miRisten in AML
-
Strategic Metals Reports Promising Results From the Rusty and Ranch Projects
-
Golden Minerals Reports Third Quarter 2026 Financial Results
-
OBI Pharma Signs Collaboration and License Agreement with Novartis
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 16
-
Blue Chip Capital Group Announces Quotation of its Common Stock on the OTCID and Updates Status of Initial Regulatory Compliance
-
Cardiff Lexington Announces Third Quarter 2026 Financial Results
-
Emerging Growth Research Highlights Criticality of First Phosphate G7-Backed LFP Battery Onshoring Solution as Cleantech Sector Accelerates Post U.S. Midterms
-
Presidio Property Trust, Inc. Announces Earnings for the Quarter Ended September 30, 2026
-
Sekur Private Data Ltd. Provides Update on Expected Closing of Non-Brokered Private Placement
-
iFabric Corp Announces Record Revenues for Q3 2026 and the Nine Months Ended September 30, 2026
-
RenX Enterprises Reports Record Third Quarter Revenue of $4.49 Million, Up 27.6% Year Over Year
-
Aptevo Provides 3Q26 Business Update Highlighting Growing Momentum for Mipletamig and Reports Third Quarter Financial Results
-
Gladstone Capital Corporation Earnings Call and Webcast Information
-
Sharecare Partners With HomeTown Health to Bring AskMD, Funded Through the GREAT Health Program, to More Rural Hospitals and Patients Across Georgia
-
Wi2Wi Reports 35% Revenue Growth to US$2.36M and Returns to Profitability with US$268K Net Income in Q3 2026
-
Ainos Reports Third Quarter 2026 Results and Highlights Expanding AI Nose Commercial Momentum
-
Westell Technologies, Inc. Announces Its Commencing a Tender Offer
-
Rescue Intellitech Expands Professional Decontamination Portfolio for Fire Departments with DeconWasher(TM) Pro S
-
MicroVision Lidar Powers Commercial Driverless Trucking at Scale with Kodiak AI
-
Expecting a Refund but Owe Back Taxes? Clear Start Tax Explains How the IRS Offset Program Takes It First
-
SMX: The Future of Gold Will Be Defined by What We Know About It -Powering Verified Trade and Tokenisation
-
Hawai‘i Falls to North Dakota State, Bowl Hopes Dashed
-
Big Mamma Founder Tigrane Seydoux Brings Italian Restaurant Group to Florida
-
Park Jin-young Denies Cult Allegations Against Firstfruits Group
Wellgistics Health (NASDAQ:WGRX) Accelerates Platform Growth in Q2 With 116 Manufacturer Partnerships, 12,400+ New Products, and 275+ Pharmacies Added to Its Expanding Tech Based Drug Ecosystem
TAMPA, FL / ACCESS Newswire / June 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare technology company focused on building the future of prescription access and distribution, today announced significant Q2 2025 operational results-adding 116 new pharmaceutical manufacturer partnerships, over 12,400 new products (NDCs), and 275+ pharmacies to its national platform.
This expansion reflects Wellgistics' accelerating momentum in creating a modern drug ecosystem-one that aims to connect manufacturers directly to pharmacies, providers, employers, and patients through a fully integrated, AI-powered infrastructure designed to streamline fulfillment, reduce costs, and bypass legacy bottlenecks.
"We're in hyper structural transformation mode," said Brian Norton, CEO of Wellgistics Health. "Pharma companies are signaling a shift. They want partners who can deliver speed, visibility, and direct access-not more layers of complexity. Every new manufacturer, every new product, and every new pharmacy is helping us rewire how prescriptions move in this country. We're laying the foundation for real-time, patient-first drug access at national scale."
As Wellgistics continues to advance toward direct-to-patient care programs, the company intends to leverage its expanding distribution, fulfillment, and pharmacy network to support new models of care-aligning pharmaceutical manufacturers with a streamlined path to market while offering patients faster, more transparent prescription access.
The Wellgistics platform spans the full prescription journey-from wholesale distribution and digital Rx routing to pharmacy dispensing and Hub Services including eligibility, prior authorization, adherence tracking, and patient engagement. With thousands of pharmacies on board and manufacturer demand accelerating, Wellgistics seeks to be a vital infrastructure partner for reshaping prescription drug delivery in the U.S.
About Wellgistics Health
Wellgistics Health (NASDAQ:WGRX) is a healthcare technology company built for the $500B prescription drug market. Our AI-powered, vertically integrated platform connects pharmaceutical manufacturers directly to providers, pharmacies, employers, and patients-managing the full journey from maker to taker. From distribution and digital routing to pharmacy fulfillment and Hub Services, Wellgistics is delivering the infrastructure to power a faster, smarter, and more transparent future in prescription access.
For more information, visit www.wellgisticshealth.com.
Forward-Looking Statements
This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, Wellgistics Health's statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from Wellgistics Health's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other risks detailed in our reports and statements filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health's filings with the SEC, which are available for review at www.sec.gov.
For more information, please contact:
Media Contact: [email protected]
Investor Relations: [email protected]
Investor Relations Contact:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, NY 10036
Office: (646) 893-5835
Email: [email protected]
SOURCE: Wellgistics Health, Inc.
View the original press release on ACCESS Newswire
A.Moore--AT